Deep brain stimulation for intractable psychiatric disorders

Annual Review of Medicine

Volumn 63, Issue , 2012, Pages 511-524

  Goodman, Wayne K ^a   Alterman, Ron L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Obsessive compulsive disorder (OCD); Psychiatric disorders

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

BRAIN DEPTH STIMULATION; COMORBIDITY; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; ELECTRODE; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTRACTABLE PSYCHIATRIC DISORDER; MAJOR DEPRESSION; MENTAL DISEASE; METHODOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; OBSESSIVE COMPULSIVE DISORDER; PATIENT SAFETY; PRIORITY JOURNAL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; REVIEW; SUBTHALAMIC NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; VAGUS NERVE STIMULATION;

DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER; HUMANS; MENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84855922983     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-052209-100401     Document Type: Review

References (80)

1. Nuttin B, Cosyns P, Demeulemeester H, et al. 1999. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 354:1526 (Pubitemid 29502111)
2. Vandewalle V, van der Linden C, Groenewegen HJ, et al. 1999. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 353:724 (Pubitemid 29103812)
3. Mayberg HS, Lozano AM, Voon V, et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45:651-60 (Pubitemid 40320700)
4. Ackermans L, Duits A, van der Linden C, et al. 2011. Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain 134:832-44
5. Goodman WK, Insel TR. 2009. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol. Psychiatry 65:263-66
6. Pressman J. 1998. Last Resort: Psychosurgery and the Limits of Medicine. Cambridge, UK: Cambridge Univ. Press
7. Heller AC, Amar AP, Liu CY, et al. 2006. Surgery of the mind and mood: a mosaic of issues in time and evolution. Neurosurgery 59:720-33; discussion 33-39 (Pubitemid 44579564)
8. Kopell BH, Rezai AR. 2003. Psychiatric neurosurgery: a historical perspective. Neurosurg. Clin. N. Am. 14:181-97, vii (Pubitemid 36514459)
9. Rezai AR, Machado AG, Deogaonkar M, et al. 2008. Surgery for movement disorders. Neurosurgery 62(Suppl. 2):809-38; discussion 38-39
10. Tagliati M, Shils J, Sun C, et al. 2004. Deep brain stimulation for dystonia. Exp. Rev. Med. Devices 1:33-41 (Pubitemid 40220417)
11. DiLorenzo DJ, Jankovic J, Simpson RK, et al. 2010. Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up. Mov. Disord. 25:232-38
12. Okun MS, Bowers D, Springer U, et al. 2004. What's in a "smile?" Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase 10:271-79 (Pubitemid 39585766)
13. Haq IU, Foote KD, Goodman WG, et al. 2011. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. NeuroImage 54(Suppl. 1):S247-55
14. Kringelbach ML, Jenkinson N, Owen SL, et al. 2007. Translational principles of deep brain stimulation. Nat. Rev. Neurosci. 8:623-35 (Pubitemid 47093935)
15. Chang CH, Chen SY, Hsiao YL, et al. 2010. Hypomania with hypersexuality following bilateral anterior limb stimulation in obsessive-compulsive disorder. J. Neurosurg. 112:1299-300
16. Sun FT, Morrell MJ, Wharen RE Jr. 2008. Responsive cortical stimulation for the treatment of epilepsy. Neurotherapeutics 5:68-74 (Pubitemid 350299302)
17. Ruscio AM, Stein DJ, Chiu WT, et al. 2010. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol. Psychiatry 15:53-63
18. do Rosario-Campos MC, Leckman JF, Curi M, et al. 2005. A family study of early-onset obsessivecompulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 136B:92-97 (Pubitemid 40917536)
19. Simpson HB. 2010. Pharmacological treatment of obsessive-compulsive disorder. Curr. Top. Behav. Neurosci. 2:527-43
20. Jenike MA, Baer L, Ballantine T, et al. 1991. Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Arch. Gen. Psychiatry 48:548-55
21. Mindus P, Edman G, Andreewitch S. 1999. A prospective, long-term study of personality traits in patients with intractable obsessional illness treated by capsulotomy. Acta Psychiatr. Scand. 99:40-50 (Pubitemid 29071171)
22. Dougherty DD, Baer L, Cosgrove GR, et al. 2002. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am. J. Psychiatry 159:269-75 (Pubitemid 34126905)
23. Jung HH, Kim CH, Chang JH, et al. 2006. Bilateral anterior cingulotomy for refractory obsessivecompulsive disorder: long-term follow-up results. Stereotact. Funct. Neurosurg. 84:184-89
24. Vitek JL. 2002. Mechanisms of deep brain stimulation: excitation or inhibition. Mov. Disord. 17(Suppl. 3):S69-72 (Pubitemid 36040907)
25. McCracken CB, Grace AA. 2007. High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. J. Neurosci. 27:12601-10 (Pubitemid 350127827)
26. Greenberg BD, Rauch SL, Haber SN. 2010. Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OC D. Neuropsychopharmacology 35:317-36
27. Abelson JL, Curtis GC, Sagher O, et al. 2005. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol. Psychiatry 57:510-16 (Pubitemid 40311986)
28. Denys D, Mantione M, Figee M, et al. 2010. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch. Gen. Psychiatry 67:1061-68
29. Goodman WK, Foote KD, Greenberg BD, et al. 2010. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol. Psychiatry 67:535-42
30. Huff W, Lenartz D, Schormann M, et al. 2010. Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: outcomes after one year. Clin. Neurol. Neurosurg. 112:137-43
31. Mallet L, Polosan M, Jaafari N, et al. 2008. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N. Engl. J. Med. 359:2121-34
32. Greenberg BD, Gabriels LA, Malone DA Jr, et al. 2010. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol. Psychiatry 15:64-79
33. de Koning PP, Figee M, van den Munckhof P, et al. 2011. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr. Psychiatry Rep. 13:274-82
34. Simon GE, VonKorff M, Piccinelli M, et al. 1999. An international study of the relation between somatic symptoms and depression. N. Engl. J. Med. 341:1329-35 (Pubitemid 29503571)
35. Heim C, Newport DJ, Mletzko T, et al. 2008. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33:693-710
36. Kessler RC, Berglund P, Demler O, et al. 2003. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095-105 (Pubitemid 37432885)
37. Ustun TB, Ayuso-Mateos JL, Chatterji S, et al. 2004. Global burden of depressive disorders in the year2000. Br. J. Psychiatry 184:386-92 (Pubitemid 38624764)
38. Moscicki EK. 1997. Identification of suicide risk factors using epidemiologic studies. Psychiatr. Clin. North Am. 20:499-517 (Pubitemid 27418720)
39. Whooley MA, de Jonge P, Vittinghoff E, et al. 2008. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300:2379-88
40. Glymour MM, Maselko J, Gilman SE, et al. 2010. Depressive symptoms predict incident stroke independently of memory impairments. Neurology 75:2063-70
41. Rush AJ, Trivedi MH, Wisniewski SR, et al. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR?D report. Am. J. Psychiatry 163:1905-17 (Pubitemid 44807782)
42. Connolly KR, Thase ME. 2011. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 71:43-64
43. Kellner CH, Tobias KG, Wiegand J. 2010. Electrode placement in electroconvulsive therapy (ECT): a review of the literature. J. ECT 26:175-80
44. Mathew SJ, Price RB, Charney DS. 2008. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am. J. Med. Genet. C Semin. Med. Genet. 148 C:89-98 (Pubitemid 351705126)
45. MaloneDAJr, Dougherty DD, Rezai AR, et al. 2009. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol. Psychiatry 65:267-75
46. Kennedy SH, Giacobbe P, Rizvi SJ, et al. 2011. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am. J. Psychiatry 168:502-10
47. Jimenez F, Velasco F, Salin-Pascual R, et al. 2005. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 57:585-93
48. Sartorius A, Kiening KL, Kirsch P, et al. 2010. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol. Psychiatry 67:e9-e11
49. Foltynie T, HarizM I. 2010. Surgical management of Parkinson's disease. Exp. Rev. Neurother. 10:903-14
50. Bronstein JM, Tagliati M, Alterman RL, et al. 2011. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch. Neurol. 68:165-71
51. Follett KA, Weaver FM, Stern M, et al. 2010. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 362:2077-91
52. Mikos A, Pavon J, Bowers D, et al. 2010. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease. Parkinsonism Relat. Disord. 16:324-28
53. Gologorsky Y, Ben-Haim S, Moshier EL, et al. 2011. Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson's disease increases the risk of adverse neurological sequelae. Neurosurgery 69:294-99
54. Sansur CA, Frysinger RC, Pouratian N, et al. 2007. Incidence of symptomatic hemorrhage after stereotactic electrode placement. J. Neurosurg. 107:998-1003 (Pubitemid 350255215)
55. Doshi PK. 2011. Long-term surgical and hardware-related complications of deep brain stimulation. Stereotact. Funct. Neurosurg. 89:89-95
56. Boviatsis EJ, Stavrinou LC, Themistocleous M, et al. 2010. Surgical and hardware complications of deep brain stimulation. Aseven-year experience and review of the literature. Acta Neurochir. (Wien) 152:2053-62
57. Paluzzi A, Belli A, Bain P, et al. 2006. Operative and hardware complications of deep brain stimulation for movement disorders. Br. J. Neurosurg. 20:290-95 (Pubitemid 44863788)
58. Oh MY, Abosch A, Kim SH, et al. 2002. Long-term hardware-related complications of deep brain stimulation. Neurosurgery 50:1268-74; discussion 74-76
59. Schlaepfer TE, Fins JJ. 2010. Deep brain stimulation and the neuroethics of responsible publishing: when one is not enough. JAMA 303:775-76
60. Shapira NA, Okun MS, Wint D, et al. 2006. Panic and fear induced by deep brain stimulation. J. Neurol. Neurosurg. Psychiatry 77:410-12
61. McNeely HE, Mayberg HS, Lozano AM, et al. 2008. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J. Nerv. Ment. Dis. 196:405-10 (Pubitemid 351684751)
62. Levkovitz Y, Roth Y, Harel EV, et al. 2007. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin. Neurophysiol. 118:2730-44 (Pubitemid 350180620)
63. Langston JW, Forno LS, Rebert CS, et al. 1984. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292:390-94 (Pubitemid 14190114)
64. Krishnan V, Nestler EJ. 2011. Animal models of depression: molecular perspectives. Curr. Top. Behav. Neurosci. 7:121-47
65. Li B, Piriz J, Mirrione M, et al. 2011. Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature 470:535-39
66. Fins JJ, Mayberg HS, Nuttin B, et al. 2011. Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff. (Millwood ) 30:302-11
67. Goodman W. 2011. Electroconvulsive therapy in the spotlight. N. Engl. J. Med. 364:1785-87
68. George MS. 2010. Transcranial magnetic stimulation for the treatment of depression. Exp. Rev. Neurother. 10:1761-72
69. O'Reardon JP, Solvason HB, Janicak PG, et al. 2007. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol. Psychiatry 62:1208-16 (Pubitemid 350060890)
70. Rush AJ, Marangell LB, Sackeim HA, et al. 2005. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol. Psychiatry 58:347-54 (Pubitemid 41219702)
71. Rush AJ, Sackeim HA, Marangell LB, et al. 2005. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol. Psychiatry 58:355-63 (Pubitemid 41219703)
72. Anderson D, Ahmed A. 2003. Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report. J. Neurosurg. 98:1104-8 (Pubitemid 36460903)
73. Aouizerate B, Cuny E, Bardinet E, et al. 2009. Distinct striatal targets in treating obsessive-compulsive disorder and major depression. J. Neurosurg. 111:775-79
74. Franzini A, Messina G, Gambini O, et al. 2010. Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol. Sci. 31:353-59
75. Sturm V, Lenartz D, Koulousakis A, et al. 2003. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive-and anxiety-disorders. J. Chem. Neuroanat. 26:293-99 (Pubitemid 38077152)
76. Bikson M, Bulow P, Stiller JW, et al. 2008. Transcranial direct current stimulation for major depression: a general system for quantifying transcranial electrotherapy dosage. Curr. Treat. Options Neurol. 10:377-85
77. Jimenez-Ponce F, Velasco-Campos F, Castro-Farfan G, et al. 2009. Preliminary study in patients with obsessive-compulsive disorder treated with electrical stimulation in the inferior thalamic peduncle. Neurosurgery 65:203-9; discussion 209
78. Schlaepfer TE, Cohen MX, Frick C, et al. 2008. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33:368-77 (Pubitemid 350243349)
79. Bewernick BH, Hurlemann R, Matusch A, et al. 2010. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol. Psychiatry 67:110-16
80. Neimat JS, Hamani C, Giacobbe P, et al. 2008. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am. J. Psychiatry 165:687-93 (Pubitemid 351810536)